HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES

被引：0
|
作者：
DEPALMA, L
机构：
来源：
PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT | 1995年 / 6卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [1] HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES
    GORSE, GJ
    SCHWARTZ, DH
    GRAHAM, BS
    MATTHEWS, TJ
    STABLEIN, DM
    FREY, SE
    BELSHE, RB
    CLEMENTS, ML
    WRIGHT, PF
    EIBL, M
    FAST, PE
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 98 (02): : 178 - 184
  • [2] HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA
    GORSE, GJ
    ROGERS, JH
    PERRY, JE
    NEWMAN, FK
    FREY, SE
    PATEL, GB
    BELSHE, RB
    SCHWARTZ, DH
    CLEMENTS, ML
    KEEFER, M
    DOLIN, R
    MCELRATH, J
    COREY, L
    GRAHAM, BS
    WRIGHT, PF
    STABLEIN, DM
    MATTHEWS, TJ
    BOLOGNESI, D
    MESTECKY, J
    WALKER, MC
    FAST, PE
    VACCINE, 1995, 13 (02) : 209 - 214
  • [3] DEVELOPMENT OF A VACCINIA RECOMBINANT DERIVED SUBUNIT HIV-1 GP160 CANDIDATE VACCINE
    BARRETT, N
    MITTERER, A
    GERENCER, M
    EIBL, J
    EIBL, M
    GALLO, RC
    MOSS, B
    DORNER, F
    VACCINES FOR SEXUALLY TRANSMITTED DISEASES, 1989, : 244 - 249
  • [4] EFFECT OF A RECOMBINANT HIV GP160 VACCINE ON MONOKINE PRODUCTION
    DOOLEY, DP
    COX, RA
    LOONEY, DJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 83 (02): : 192 - 196
  • [5] Immunisation with gp160 in HIV-1 infection
    Flala, C
    Stewart, GT
    LANCET, 1999, 354 (9182): : 948 - 948
  • [6] CLINICAL AND VIROLOGIC RESPONSES TO A RECOMBINANT VACCINIA HIV-1 GP160 VACCINE (HIVAC-1E)
    COREY, L
    COLLIER, A
    COOMBS, R
    ARDITTI, D
    HU, SL
    GREENBERG, P
    MCLAREN, C
    MARTIN, R
    DRAGAVON, J
    CHALOUPKA, K
    CLINICAL RESEARCH, 1989, 37 (02): : A562 - A562
  • [7] Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine
    Lambert, JS
    Viscidi, R
    Walker, MC
    Clayman, B
    Winget, M
    Wolff, M
    Schwartz, DH
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (03) : 302 - 308
  • [8] IMMUNIZATION WITH RECOMBINANT GP160 PROLONGS THE SURVIVAL OF HIV-1 TRANSGENIC MICE
    SHIRAI, A
    KLINMAN, DM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (10) : 979 - 983
  • [9] Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration
    Gorse, GJ
    McElrath, MJ
    Matthews, TJ
    Hsieh, RH
    Belshe, RB
    Corey, L
    Frey, SE
    Kennedy, DJ
    Walker, MC
    Eibl, MM
    VACCINE, 1998, 16 (05) : 493 - 506
  • [10] CHARACTERIZATION OF SERUM ANTIBODY-RESPONSES TO RECOMBINANT HIV-1 GP160 VACCINE BY ENZYME-IMMUNOASSAY
    VISCIDI, R
    ELLERBECK, E
    GARRISON, L
    MIDTHUN, K
    CLEMENTS, ML
    CLAYMAN, B
    FERNIE, B
    SMITH, G
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) : 1251 - 1256
12345